Atlas Trials

Novel Dose Escalation to Predict Treatment With Hydroxyurea

Clinical trial NCT02042222 · COMPLETED

Trial details

NCT number
NCT02042222
Sponsor
Baylor College of Medicine
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2013-10-01
Primary completion
2020-07-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.